Annotated image

Bevacizumab effect over contrast-enhancement areas

Axial T1 C+
Modality: Annotated image (Axial T1 C+)

- “ This case illustrates a common follow-up for glioblastoma in which an antiangiogenic chemotherapy (bevacizumab) was introduced after tumour recurr...”

View full size version of Glioblastoma NOS (bevacizumab pseudoresponse)

Updating… Please wait.
Loadinganimation

Alert accept

Error Unable to process the form. Check for errors and try again.

Alert accept Thank you for updating your details.